Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial-Reference-Cited by-同舟云学术

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Published:2015-01 Issue:1 Volume:169 Page:25-30
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Granger Christopher B.,Lopes Renato D.,Hanna Michael,Ansell Jack,Hylek Elaine M.,Alexander John H.,Thomas Laine,Wang Junyuan,Bahit M. Cecilia,Verheugt Freek,Lawrence Jack,Xavier Denis,Wallentin Lars

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

2. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

3. Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

4. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

5. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale;Lopes;Am Heart J,2010

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery;Revista Portuguesa de Cardiologia;2024-09

2. Development and validation of a clinical decision support system to prevent anticoagulant duplications;International Journal of Medical Informatics;2024-07

3. Managing the Patient on Antiplatelet, Anticoagulation, Beta Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Receptors Blockers: The Anesthesia Perspective;Principles of Perioperative Safety and Efficiency;2024

4. Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review;Cureus;2023-10-02

5. The Role of Biomarkers, Metabolomics, and COVID-19 in Venous Thromboembolism—A Review of Literature;International Journal of Molecular Sciences;2023-08-29